论文期刊

取消

高级检索

检索历史清除

首页> Therapeutic advances in medical oncology> Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.

导出 OA

翻译打印收藏纠错

作者： Elena,Verzoni ^[1] ; Paolo,Grassi ^[1] ; Raffaele,Ratta ^[1] ; Monica,Niger ^[1] ; Filippo,De Braud ^[1] ; Riccardo,Valdagni ^[2] ; Giuseppe,Procopio ^[3]

作者单位： Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ^[1] Prostate Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ^[2] Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian 1, 20133 Milano, Italy. ^[3]

关键词 abiraterone acetate cardiovascular risk factors castration-resistant prostatic cancer prostate cancer retrospective study safety

DOI 10.1177/1758834016656493

PMID 27583024

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览31

Therapeutic advances in medical oncology

Therapeutic advances in medical oncology

2016年8卷5期

323-30页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览31

Therapeutic advances in medical oncology

点击下载本期目录封面

Therapeutic advances in medical oncology

2016年8卷5期

323-30页

相关期刊

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷